Susumu Nakata

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Cell Cycle Arrest

Pluripotent Stem Cells

Papillary Thyroid

Top Venues

Cancer gene therapy

Future medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Kaito Ohta, Hiromi Ii, Mei Takahashi, Chiami Moyama, Shota Ando, Masaya Mori, Maho Masuda, Hisanori Nambu, Susumu Nakata, Naoto Kojima
Structure-activity relationships study of N -ethylene glycol-comprising alkyl heterocyclic carboxamides against A549 lung cancer cells. Future medicinal chemistry (2024)
Tomoya Ueno, Shohei Otani, Yuki Date, Yu Katsuma, Yuma Nagayoshi, Tomoko Ito, Hiromi Ii, Susumu Kageyama, Susumu Nakata, Kosei Ito
Myc upregulates Ggct, γ-glutamylcyclotransferase to promote development of p53-deficient osteosarcoma. Cancer science (2024)
Keiko Taniguchi, Susumu Kageyama, Chiami Moyama, Shota Ando, Hiromi Ii, Eishi Ashihara, Mano Horinaka, Toshiyuki Sakai, Shigehisa Kubota, Akihiro Kawauchi, Susumu Nakata
γ-Glutamylcyclotransferase, a novel regulator of HIF-1α expression, triggers aerobic glycolysis. Cancer gene therapy (2021)
Seisuke Tanigawa, Mitsugu Fujita, Chiami Moyama, Shota Ando, Hiromi Ii, Yasushi Kojima, Teruaki Fujishita, Masahiro Aoki, Hayato Takeuchi, Takumi Yamanaka, Yoshinobu Takahashi, Naoya Hashimoto, Susumu Nakata
Inhibition of Gli2 suppresses tumorigenicity in glioblastoma stem cells derived from a de novo murine brain cancer model. Cancer gene therapy 28 (12) (2021)